Constitutional trisomy 8 and behcet syndrome

American Journal of Medical Genetics, Part A

Volumn 149, Issue 5, 2009, Pages 982-986

  Becker, Kristin ^a,b   Fitzgerald, Oliver ^c   Green, Andrew J ^d   Keogan, Mary ^e   Newbury Ecob, Ruth ^f   Greenhalgh, Lynn ^g   Withers, Stephen ^h   Hollox, Edward J ^i,j   Aldred, Patricia M R ^i,j   Armour, John A L ⁱ  

^a GLAN CLWYD HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^e BEAUMONT HOSPITAL   (Ireland)

^f ST MICHAEL'S HOSPITAL   (United Kingdom)

^g ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^h Watkins Medical Centre   (Australia)

ⁱ UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

Behcet syndrome; Defensin genes; Trisomy 8

Indexed keywords

ALPHA DEFENSIN; AZATHIOPRINE; BENZYDAMINE; CHLORHEXIDINE GLUCONATE; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; BEHCET DISEASE; CASE REPORT; CHROMOSOME 8; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS CALLOSUM AGENESIS; DEFA1A3 GENE; DRUG DOSE REDUCTION; FEMALE; GENE; GENE DOSAGE; GENE FREQUENCY; GENITAL ULCER; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MALE; MALFORMATION SYNDROME; MOUTH ULCER; NONSENSE MUTATION; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SKIN MANIFESTATION; STEROID THERAPY; TRISOMY 8;

ADOLESCENT; ADULT; ALPHA-DEFENSINS; BEHCET SYNDROME; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENE DOSAGE; HUMANS; MALE; TRISOMY; YOUNG ADULT;

EID: 66849089767     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.32756     Document Type: Article

References (20)

1. Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B. 2008. Behcet's disease associated with bone marrow failure in Korean patients: Clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology 47:1228-1230.
2. Aldred PM, Hollox EJ, Armour JA. 2005. Copy number polymorphism and expression level variation ofthe human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet 14:2045-2052.
3. Ando S, Maemori M, Sakai H, Ando S, Shiraishi H, Sakai K, Ruhnke GW. 2005. Constitutional trisomy 8 mosaicism with myelodysplastic syndrome complicated by intestinal Behcet disease and antithrombin III deficiency. Cancer Genet Cytogenet 162:172-175.
4. Baidas S, Chen TJ, Kolev V, Wong LJ, Imholte J, Qin N, Meck J. 2004. Constitutional trisomy 8 mosaicism due to meiosis II non-disjunction in a phenotypically normal woman with hematologic abnormalities. Am J Med Genet Part A 124A:383-387.
5. Brady AF, Waters CS, Pocha MJ, Brueton LA. 2000. Chronic myelomo- nocytic leukaemia in a child with constitutional partial trisomy 8 mosaicism. Clin Genet 58:142-146.
6. Disease ISGfBs. 1990. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet 335:1078-1080.
7. Fine LA, Hoffman LD, Hoffman MD. 2007. Aphthous ulcerations associated with trisomy 8-postive myelodysplastic syndrome. J Am Acad Dermatol 57:S38-S41.
8. Goossens PH, Verburg RJ, Breedveld FC. 2001. Remission of Behcet s syndrome with tumour necrosis factor alpha blocking therapy. Ann Rheum Dis 60:637.
9. Hollox EJ, Armour JA, Barber JC. 2003. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet 73:591-600.
10. Kuttikat A, Haskard D, Chakravarty K. 2005. Behcet s disease associated with trisomy 8 in a male Caucasian patient from Great Britain-a case report. Clin Exp Rheumatol 23:S108-S109.
11. Lehrer RI, Ganz T, Selsted ME. 1991. Defensins: Endogenous antibiotic peptides of animal cells. Cell 64:229-230.
12. Lin YC, Liang TH, Chang HN, Lin JS, Lin HY. 2008. Behcet disease associated with myelodysplatic syndrome. J Clin Rheumatol 14:169-174.
13. Linzmeier RM, Ganz T. 2005. Human defensin gene copy number polymorphisms: Comprehensive analysis ofindependent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics 86:423-430.
14. Nawata R, Shinohara K, Takahashi T, Yamada T, Katsuki K. 1999. Refractory anemia with trisomy-8 complicated by Behcet s disease with elevated levels of inflammatory cytokines. Rinsho Ketsueki 40:1100-1104.
15. Oh EJ, Yoon JS, Park YJ, Cho CS, Kim BK. 1999. Behcet's disease associated with myelodysplastic syndrome: A case report. J Korean Med Sci 14:685-687.
16. Ohno E, Ohtsuka E, Watanabe K, Kohno T, Takeoka K, Saburi Y, Kikuchi H, Nasu M. 1997. Behcet s disease associated with myelodysplastic syndromes. A case report and a review of the literature. Cancer 79:262-268.
17. Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomiche- lakis NN. 2001. Effect of infliximab on sight-threatening panuveitis in Behcet s disease. Lancet 358:295-296.
18. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. 2001.Treatment ofintestinal Behcet s syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49:725-728.
19. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA, Bloomfield CD, de La Chapelle A, Krahe R. 2001. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 98:1124-1129.
20. Yano K, Eguchi K, Migita K, Takashima H, Tamura M, Izumino K, Sasagawa I, Sadamori N, Nagataki S. 1996. Behcet s disease complicated with myelodysplastic syndrome: A report oftwo cases and review ofthe literature. Clin Rheumatol 15:91 -93.